American Oriental Bioengineering, Inc. Completes Acquisition Of Heilongjiang Qitai Pharmaceutical Limited

HONG KONG--(BUSINESS WIRE)--July 27, 2006--American Oriental Bioengineering, Inc. (AMEX:AOB - News): American Oriental Bioengineering, Inc. (AMEX:AOB - News), a leading manufacturer and distributor of plant based pharmaceutical (PBP) and plant based nutraceutical (PBN) products in China, announced today the closing of the acquisition of Heilongjiang Qitai Pharmaceutical Limited (HQPL), a distributor of pharmaceutical products throughout China. HQPL specializes in pharmaceutical product distribution and is headquartered in the Heilongjiang province.

MORE ON THIS TOPIC